---
$id: https://graph.org.ai/products/commodity/51334409
$type: Product
source: UNSPSC
code: "51334409"
title: "Fosenazide"
class: "51334400"
classTitle: "Antipsychotics, synthesized"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fosenazide

**UNSPSC Code**: 51334409
**Class**: [Antipsychotics, synthesized](Antipsychotics, synthesized.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antipsychotic agent and antidepressant with the molecular formula C14H15N2O2P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 16C19Z7F4I, chemically known as (diphenylphosphinyl)acetic acid, hydrazide but generally known as fosenazide, which bears US NIH Compound Identifier 27918. European Medicines Agency schedules Fosenazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07794MIG. The term FOSENAZIDE is an International Non-Proprietary Name. FOSENAZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, FOSENAZIDE remains the US FDA Preferred Term for this commodity. Fosenazide bears US NLM identifiers UMLS ID C1880846 and NCI Concept Code C65758. SMILES: P(=O)(CC(=O)NN)(C1CCCCC1)C1CCCCC1.

